PUBLISHER: The Business Research Company | PRODUCT CODE: 1945570
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945570
A medical needle-free injection is a device that administers medications or vaccines through the skin using high-pressure technology, eliminating the need for a traditional needle. It works by creating a fine stream of liquid that penetrates the skin, enabling the quick and painless delivery of drugs.
The primary types of medical needle-free injectors include jet-based, spring-based, laser-powered, and vibration-based injectors. Jet-based needle-free injectors use a high-pressure liquid stream to deliver medication through the skin without needles, offering a safer and less painful alternative for administering vaccines and insulin. These injectors can deliver medication in different modes, such as subcutaneous, intramuscular, intradermal (ID), and intravenous (IV), and are used for a variety of applications including vaccine administration, insulin delivery, pain management, oncology treatments, and more. They are utilized by various end-users, including hospitals, clinics, home care settings, research laboratories, and others.
Tariffs are impacting the medical needle free injection market by increasing costs of imported precision components, microfluidic assemblies, electronic control units, and medical-grade plastics used in advanced injector systems. Healthcare device manufacturers in North America and Europe are most affected due to reliance on globally sourced high-precision parts, while Asia-Pacific faces cost pressures in export-oriented manufacturing. These tariffs are increasing device production costs and affecting pricing strategies for hospitals and clinics. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic medical device innovation and assembly capabilities.
The medical needle free injection market research report is one of a series of new reports from The Business Research Company that provides medical needle free injection market statistics, including medical needle free injection industry global market size, regional shares, competitors with a medical needle free injection market share, detailed medical needle free injection market segments, market trends and opportunities, and any further data you may need to thrive in the medical needle free injection industry. This medical needle free injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical needle free injection market size has grown rapidly in recent years. It will grow from $16.13 billion in 2025 to $18.19 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising vaccination programs, concerns over needle-stick injuries, growth in outpatient care settings, increasing acceptance of non-invasive therapies.
The medical needle free injection market size is expected to see rapid growth in the next few years. It will grow to $29.21 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing investments in advanced drug delivery platforms, rising demand for self-administered therapies, expansion of biologics and vaccines pipeline, growing focus on patient-centric medical devices, technological advancements in microfluidic injection systems. Major trends in the forecast period include increasing adoption of painless drug delivery systems, rising demand for needle-free vaccination technologies, growing integration of electronically controlled injection devices, expansion of home-based self-administration solutions, enhanced focus on patient comfort and compliance.
The growing number of diabetes patients is anticipated to drive the expansion of the medical needle-free injection market. Diabetes is a long-term condition where the body struggles to regulate blood glucose levels effectively. The increasing prevalence of diabetes is primarily linked to the rising incidence of obesity, a major risk factor for type 2 diabetes. Needle-free injection systems offer a painless, non-invasive method for administering insulin or other medications using high-pressure technology. These systems reduce pain, ease needle-related anxiety, and improve patient compliance with treatment regimens. For example, according to a June 2024 report from the National Health Service (NHS), a UK-based government agency, 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023-an 18% increase from 3,065,825 cases in 2022. This rising number of diabetes cases is contributing to the growth of the medical needle-free injection market.
Key players in the medical needle-free injection market are focusing on technological innovations such as jet-based injection systems to enhance drug delivery and increase patient comfort. These systems use high-pressure liquid streams to deliver medication without needles, providing a safer and more comfortable alternative to traditional injections. For instance, in November 2024, Sol-Millennium Medical Group, a US-based medical device manufacturer, introduced the InsuJet needle-free insulin injector in Canada. The device employs high-pressure jet technology to administer insulin without needles, aiming to decrease pain, reduce anxiety, and minimize needle-associated risks, thereby promoting better adherence to treatment.
In May 2024, Serum Institute of India (SII), an India-based biotechnology company, acquired a 20% stake in IntegriMedical for an undisclosed sum. The acquisition is intended to combine SII's vaccine production capabilities with IntegriMedical's expertise in needle-free injection technology, with the goal of accelerating the development and worldwide distribution of safer and more efficient vaccine delivery methods. This partnership aims to enhance patient comfort and reduce needle-related injuries. IntegriMedical is a US-based biotechnology company that specializes in the development and commercialization of needle-free drug delivery systems.
Major companies operating in the medical needle free injection market are PharmaJet Inc., Portal Instruments Inc., Medical International Technology Inc. (MIT), NuGen Medical Devices Inc., Crossject SA, Bioject Medical Technologies Inc., Antares Pharma Inc., Ferring Pharmaceuticals, Akra Dermojet, PenJet Corporation, Vaxxas Pty Ltd., Micron Biomedical Inc., Injex Pharma AG, Sol-Millennium Medical Group, LTS Lohmann Therapie-Systeme, Enable Injections, Comfort-in, Needle Free India, Glide Pharma, Aijex Pharma, QS Medical Technology, IntegriMedical, NovaXS Biotech
North America was the largest region in the medical needle free injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical needle free injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical needle free injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical needle-free injection market consists of sales of gas-powered needle-free injectors, electroporation-based injectors, transdermal patch systems, and powder injector systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Needle Free Injection Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical needle free injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical needle free injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical needle free injection market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.